Solid biosciences to participate in virtual fireside chat at the chardan 5th annual genetic medicines manufacturing summit

Cambridge, mass., april 20, 2021 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company focused on advancing meaningful therapies for duchenne muscular dystrophy (duchenne), today announced that joel schneider, ph.d., chief operating officer, and louise perry, head of technical operations, will participate in a virtual fireside chat at the chardan 5th annual genetic medicines manufacturing summit on tuesday, april 27, 2021 at 10:30 am et.
SLDB Ratings Summary
SLDB Quant Ranking